Previous studies reported that avasimibe can decrease the expression of sterol regulatory element-binding protein by disrupting the balance of cholesterol metabolism to inhibit the proliferation of many kinds of cancer cells [14, 15]. The gene discussed is CNBP; the disease is cancer.